33 research outputs found
HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014
Data from Ukraine on risk factors for HIV acquisition are limited. We describe the characteristics of individuals testing for HIV in the main testing centres of the Ukrainian capital Kiev, including HIV risk factors, testing rates, and positivity rates. As part of a larger study to estimate HIV incidence within Kiev City, we included questions on possible risk factors for HIV acquisition and testing history to existing systems in 4 infectious disease clinics. Data were provided by the person requesting an HIV test using a handheld electronic tablet. All persons (≥16 yrs) presenting for an HIV test April 2013-March 2014 were included. Rates per 100,000 were calculated using region-specific denominators for Kiev. During the study period 6370 individuals tested for HIV, equivalent to a testing rate of 293.2 per 100,000. Of these, 467 (7.8%) were HIV-positive, with the highest proportion positive among 31-35 year olds (11.2%), males (9.4%), people who inject drugs (PWID) (17.9%) and men who have sex with men (MSM) (24.1%). Using published population size estimates of MSM, diagnosis rates for MSM ranged from 490.6 to 1548.3/100,000. A higher proportion of heterosexual women compared to heterosexual men reported contact with PWID, (16% vs. 4.7%) suggesting a bridging in risk between PWID and their sexual partners. Collection of HIV risk factor information in Kiev, essential for the purposes of developing effective HIV prevention and response tools, is feasible. The high percentage of MSM among those testing positive for HIV, may indicate a significant level of undisclosed sex between men in national figures
Long-term Mortality in HIV-Positive Individuals Virally Suppressed for >3 Years With Incomplete CD4 Recovery
Virally suppressed HIV-positive individuals on combination antiretroviral therapy who do not achieve a CD4 count >200 cells/µL have substantially increased long-term mortality. The increased mortality was seen across different patient groups and for all causes of deat
A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key Populations
Background: The human immunodeficiency virus (HIV) epidemic in Ukraine has been driven by a rapid rise among people who inject drugs, but recent studies have shown an increase through sexual transmission. Methods: Protease and reverse transcriptase sequences from 876 new HIV diagnoses (April 2013–March 2015) in Kiev were linked to demographic data. We constructed phylogenetic trees for 794 subtype A1 and 64 subtype B sequences and identified factors associated with transmission clustering. Clusters were defined as ≥2 sequences, ≥80% local branch support, and maximum genetic distance of all sequence pairs in the cluster ≤2.5%. Recent infection was determined through the limiting antigen avidity enzyme immunoassay. Sequences were analyzed for transmitted drug resistance mutations. Results Thirty percent of subtype A1 and 66% of subtype B sequences clustered. Large clusters (maximum 11 sequences) contained mixed risk groups. In univariate analysis, clustering was significantly associated with subtype B compared to A1 (odds ratio [OR], 4.38 [95% confidence interval {CI}, 2.56–7.50]); risk group (OR, 5.65 [95% CI, 3.27–9.75]) for men who have sex with men compared to heterosexual males; recent, compared to long-standing, infection (OR, 2.72 [95% CI, 1.64–4.52]); reported sex work contact (OR, 1.93 [95% CI, 1.07–3.47]); and younger age groups compared with age ≥36 years (OR, 1.83 [95% CI, 1.10–3.05] for age ≤25 years). Females were associated with lower odds of clustering than heterosexual males (OR, 0.49 [95% CI, .31–.77]). In multivariate analysis, risk group, subtype, and age group were independently associated with clustering (P < .001, P = .007, and P = .033, respectively). Eighteen sequences (2.1%) indicated evidence of transmitted drug resistance. Conclusions Our findings suggest high levels of transmission and bridging between risk groups
The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post-Combination Antiretroviral Therapy Era
The incidence of AIDS was higher in patients with a current CD4 count of 500-749 cells/µL compared to 750-999 cells/µL, but did not decrease further at higher CD4 levels. Results were similar in those virologically suppressed on combination antiretroviral therapy, suggesting immune reconstitution is incomplete until CD4 >750/µ
Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers
Objective: HIV controllers (HICs) spontaneously maintain HIV viral replication at low level without antiretroviral therapy (ART), a small number of whom will eventually lose this ability to control HIV viremia. The objective was to identify factors associated with loss of virological control. Methods: HICs were identified in COHERE on the basis of \ue2\u89\ua55 consecutive viral loads (VL) \ue2\u89\ua4500 copies/mL over \ue2\u89\ua51 year whilst ART-naive, with the last VL \ue2\u89\ua4500 copies/mL measured \ue2\u89\ua55 years after HIV diagnosis. Loss of virological control was defined as 2 consecutive VL >2000 copies/mL. Duration of HIV control was described using cumulative incidence method, considering loss of virological control, ART initiation and death during virological control as competing outcomes. Factors associated with loss of virological control were identified using Cox models. CD4 and CD8 dynamics were described using mixed-effect linear models. Results: We identified 1067 HICs; 86 lost virological control, 293 initiated ART, and 13 died during virological control. Six years after confirmation of HIC status, the probability of losing virological control, initiating ART and dying were 13%, 37%, and 2%. Current lower CD4/CD8 ratio and a history of transient viral rebounds were associated with an increased risk of losing virological control. CD4 declined and CD8 increased before loss of virological control, and before viral rebounds. Discussion: Expansion of CD8 and decline of CD4 during HIV control may result from repeated low-level viremia. Our findings suggest that in addition to superinfection, other mechanisms, such as low grade viral replication, can lead to loss of virological control in HICs
Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration
Background: We aimed to compare rates of virologic response and CD4
changes after combination antiretroviral (cART) initiation in
individuals infected with B and specific non-B HIV subtypes.
Methods: Using CASCADE data we analyzed HIV-RNA and CD4 counts for
persons infected >= 1996, >= 15 years of age. We used survival and
longitudinal modeling to estimate probabilities of virologic response
(confirmed HIV-RNA <500 c/ml), and failure (HIV-RNA>500 c/ml at 6 months
or >= 1000 c/ml following response) and CD4 increase after cART
initiation.
Results: 2003 (1706 B, 142 CRF02_AG, 55 A, 53 C, 47 CRF01_AE)
seroconverters were included in analysis. There was no evidence of
subtype effect overall for response or failure (p = 0.075 and 0.317,
respectively) although there was a suggestion that those infected with
subtypes CRF01_AE and A responded sooner than those with subtype B
infection [HR (95% CI): 1.37 (1.01-1.86) and 1.29 (0.96-1.72),
respectively]. Rates of CD4 increase were similar in all subtypes except
subtype A, which tended to have lower initial, but faster long-term,
increases.
Conclusions: Virologic and immunologic response to cART was similar
across all studied subtypes but statistical power was limited by the
rarity of some non-B subtypes. Current antiretroviral agents seem to
have similar efficacy in subtype B and most widely encountered non-B
infections in high-income countries
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy
OBJECTIVE: To assess whether immunodeficiency is associated with the most frequent non-AIDS-defining causes of death in the era of combination antiretroviral therapy (cART). DESIGN: Observational multicentre cohorts. METHODS: Twenty-three cohorts of adults with estimated dates of human immunodeficiency virus (HIV) seroconversion were considered. Patients were seroconverters followed within the cART era. Measurements were latest CD4, nadir CD4 and time spent with CD4 cell count less than 350 cells/microl. Outcomes were specific causes of death using a standardized classification. RESULTS: Among 9858 patients (71 230 person-years follow-up), 597 died, 333 (55.7%) from non-AIDS-defining causes. Non-AIDS-defining infection, liver disease, non-AIDS-defining malignancy and cardiovascular disease accounted for 53% of non-AIDS deaths. For each 100 cells/microl increment in the latest CD4 cell count, we found a 64% (95% confidence interval 58-69%) reduction in risk of death from AIDS-defining causes and significant reductions in death from non-AIDS infections (32, 18-44%), end-stage liver disease (33, 18-46%) and non-AIDS malignancies (34, 21-45%). Non-AIDS-defining causes of death were also associated with nadir CD4 while being cART-naive or duration of exposure to immunosuppression. No relationship between risk of death from cardiovascular disease and CD4 cell count was found though there was a raised risk associated with elevated HIV RNA. CONCLUSION: In the cART era, the most frequent non-AIDS-defining causes of death are associated with immunodeficiency, only cardiovascular disease was associated with high viral replication. Avoiding profound and mild immunodeficiency, through earlier initiation of cART, may impact on morbidity and mortality of HIV-infected patients
Glacier 15, Antisana, Ecuador: its glaciology and relations to water resources
International audienceBesides the Lewis glacier in Kenya, Glacier 15 of Antisana, Ecuador (5760–4830 m, 0.28 km2) is the only one which provides regular information regarding glacier mass balance near to the Equator (Annual Report of the World Services for the Monitoring of Glaciers, WGMS 2005) to the scientific community. The surface of the glacier had been re-constructed using aerial-photogrammetry from 1956 to 1997. Since 1994, direct measurements have been taken over the terminal zone at the glacier tongue using topography. That process has shown the changes at the glacier limits and has determined the superficial speed at the terminal zone of the tongue (ablation zone). At the ablation zone (<5100 m) a wide net of stakes have been installed in order to measure the evolution of the glacier mass each month since 1995. In addition, holes to measure accumulation have been dug in the ablation zone at the end of the hydrological year (December–January) in order to calculate the net specific annual balance. Glacier 15 has lost an average of 600 mm of water a year since 1995 (11 years). The inter-annual variation is wide: very negative balances were observed in 1995 and 2002, two positive balances in 1999 and 2000, and negative balances for the remaining years. The dynamics of the glacier show a mass balance with very noticeable fluctuations. These variations are well synchronized with the glacier evolution. The variability of the ENSO (El Niño Southern Oscillation) has been an important factor in controlling the mass evolution of the Ecuadorian glaciers and the climate conditions. Those factors caused advances and retreats on the glaciers according to La Niña (cold event) or El Niño (warm event), respectively. This study has shown the relationship between glaciology and availability of hydrological sources